In September, Christian Marcazzo joined us as Vice President and General Manager. Christian will be responsible for the day-to-day running of IDBS and growing the Informatics Solutions business of the Danaher Life Sciences Platform. Watch the interview below to hear Christian’s thoughts on everything from the future of drug...
Disaster recovery and backups are an often overlooked, but critical, component of managing an enterprise application. Both options are required to prevent catastrophic loss of data. Disaster recovery requires either off-site or multi-site storage – and organizations typically backup data every 24-hours. For events unrelated to catastrophic data loss,...
As the biologics market matures at an expected growth of 7-9% through to 2022 – reaching $3.8bn, it substantially influences the CMO/CDMO market with notable mergers and acquisitions in the space. This year we’ve seen Catalent’s acquisition of Juniper, Emergent BioSolutions’ acquisition of PaxVax and European-based cGMP, expanding its...
The biopharma space is constantly evolving thanks to the scientific community’s commitment to innovation to seek out new cures and ways to improve our health. These innovations, however, are often held back due to the often-outdated nature of commercial manufacturing. The Wall Street Journal once described pharmaceutical manufacturing processes...
Pharma and biotech companies have invested heavily in externalized research, development, and manufacturing in recent years – but their methods of sharing critical data are still rarely fit for purpose. Typically, collaborator data is simply packaged up in a PDF format and sent via email. Job well done, right?...
Despite shrinking growth in the pharmaceutical market, from double to single digit growth rates, demand for contract research organization (CRO) services is growing rapidly, according to the Business Research Company’s (BRC’s) 2018 CRO Global Market Report. Affirming CROs are on the rise, LabCorp, the world’s leading healthcare diagnostics company, has...
In August we attended The BioProcessing Summit 2018 in Boston. The event saw more than 1,000 bioprocess professionals and business leaders from around the globe gather to share practical ideas and solutions on tackling today’s bioprocess challenges. Now in its tenth year, The BioProcessing Summit is a week-long programme...
In October last year, we hosted our first ever i3 conference in North America. We enjoyed the event so much that i3 is back again this year – and this time we’re in Austin! So, why should you come to our Austin event? i3 is our premier annual customer...
Pharmaceutical companies are under escalating pressure to significantly increase the number of drugs that reach the market within a shorter timeframe, but lack the infrastructure to do so. More than ever, companies need to partner with outside firms to compress the timeline of drug development, thereby decreasing overall cost...
At the dawn of bioprocess development, biopharmaceutical manufacturing, upstream and downstream primary processing were worlds apart. This is because, in the pre-biotech days of industrial bioprocessing, the professionals in upstream, usually biologists, microbiologists, biochemists, and chemists, worked independently from the downstream professionals who were mostly chemical engineers working on...
